Login | SITEMAP | FAQS

Research & Scientists | Neurosciences | People | ID5310

 

Name: Céline S. Gonçalves

Office: I1.02

School Phone: +351 253 604 837

Email: ID5310@alunos.uminho.pt

 

 

 

Keywords: Neuro-oncology Cell signaling Transcriptomics Drug response

About


Céline S. Gonçalves
is graduated in Biochemistry (2011) and received her MSc. degree in Health Sciences (2013), both from the University of Minho.

Presently, she is a PhD student at the Life and Health Sciences Research Institute (ICVS) - Health Sciences School, University of Minho.


Fellowships

2009-2010: Research Student Fellow – Integration into Research Grant (BII) under the project: "Preparation of precursor for enantioselective synthesis of azasugar by Diels-Alder methodology" – Chemistry Research Centre - Sciences School, University of Minho

01/2014-08/2014: Research Student Fellow under the project: "The Transcriptome of the Oncogenic HOXA9 Homeoprotein in Human Glioblastoma: Functional and Clinical Relevance" (PTDC/SAU-GMG/113795/2009) – Life and Health Sciences Research Institute (ICVS) - Health Sciences School, University of Minho

09/2014-Present: PhD Student Fellow  – Life and Health Sciences Research Institute (ICVS) - Health Sciences School, University of Minho


Honors and Prizes

2005: Diploma of Merit assigned by the Rotary Club

2009: Diploma of Merit Monsenhor Elísio Araújo

2013: Best Poster Award at the XXII Porto Cancer Meeting

2013: Travel Award funded by the FAPESP

2014: PhD scholarship from the Portuguese Science Foundation (FCT)


Chapter of Book:

Céline S. Gonçalves, Tatiana Lourenço, Ana Xavier-Magalhães, Marta Pojo, Bruno M. Costa (2013). Mechanisms of Aggressiveness in Glioblastoma: Prognostic and Potential Therapeutic Insights. In: Lichtor T, editor. Evolution of the Molecular Biology ofBrain Tumors and the Therapeutic Implications: InTech.

Céline Gonçalves, Ana Xavier Magalhães and Bruno Marques Costa. (2012). Molecular Pathology of Glioma. In: Ana Xavier Magalhães and Bruno Marques Costa. Molecular Determinants of Glioma Risk and Patient Prognosis. U.S.A.: LAP LAMBERT Academic Publishing GmbH & Co. p31-55.

Selected Publications

Almeida-Rios D, Graça I, Vieira FQ, Ramalho-Carvalho J, Pereira-Silva E, Martins AT, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Histone methyltransferase PRMT6 plays an oncogenic role in prostate cancer. Oncotarget, 2016; 7(33): 53018-53028.

Pires-Luís AS, Vieira-Coimbra M, Vieira FQ, Costa-Pinheiro P, Silva-Santos R, Dias PC, Antunes L, Lobo F, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication. Epigenetics, 2015; 10(11):1033-43.

Pojo M, Gonçalves CS, Xavier-Magalhães A, Oliveira AI, Gonçalves T, Correia S, Rodrigues AJ, Costa S, Pinto L, Pinto AA, Lopes JM, Reis RM, Rocha M, Sousa N, Costa BM. A transcriptomic signature mediated by HOXA9 promotes human glioblastoma initiation, aggressiveness and resistance to temozolomide. Oncotarget, 6(10):7657-7674 (2015).

Vieira de Castro J, Gonçalves CS, Costa S, Linhares P, Vaz R, Nabiço R, Amorim J, Viana-Pereira M, Reis RM, Costa BM. Impact of TGF-ß1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumor Biology. August 2015, Volume 36, Issue 8, pp 6525-6532

Costa-Pinheiro P, Ramalho-Carvalho J, Vieira FQ, Torres-Ferreira J, Oliveira J, Gonçalves CS, Costa BM, Henrique R, Jerónimo C. MicroRNA-375 plays a dual role in prostate carcinogenesis. Clinical Epigenetics, 7(1):42 (2015).

Copyright © 2012-2016 ICVS. All rights reserved.